| __timestamp | Evotec SE | Ionis Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 12404000 | 241751000 |
| Thursday, January 1, 2015 | 18343000 | 322292000 |
| Friday, January 1, 2016 | 18108000 | 344320000 |
| Sunday, January 1, 2017 | 17614000 | 374644000 |
| Monday, January 1, 2018 | 35619000 | 414604000 |
| Tuesday, January 1, 2019 | 58432000 | 466000000 |
| Wednesday, January 1, 2020 | 63945000 | 535000000 |
| Friday, January 1, 2021 | 72200000 | 643000000 |
| Saturday, January 1, 2022 | 76642000 | 833000000 |
| Sunday, January 1, 2023 | 57519000 | 899625000 |
Infusing magic into the data realm
In the competitive landscape of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Ionis Pharmaceuticals, Inc. and Evotec SE have demonstrated contrasting strategies in their R&D investments. From 2014 to 2023, Ionis Pharmaceuticals consistently outpaced Evotec SE, with R&D expenses growing by approximately 272%, peaking in 2023. In contrast, Evotec SE's R&D spending increased by about 364% over the same period, albeit from a much smaller base. This disparity highlights Ionis's aggressive investment strategy, with its R&D expenses in 2023 being nearly 16 times that of Evotec SE. Such financial dedication underscores Ionis's strategic focus on pioneering advancements in RNA-targeted therapeutics, while Evotec SE's steady growth reflects its commitment to collaborative drug discovery. As the biotech sector evolves, these R&D trends will likely shape the future of medical innovation.
United Therapeutics Corporation or Ionis Pharmaceuticals, Inc.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for BioMarin Pharmaceutical Inc. and Ionis Pharmaceuticals, Inc.
Analyzing R&D Budgets: Sarepta Therapeutics, Inc. vs Ionis Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Ascendis Pharma A/S and Ionis Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc. or Verona Pharma plc: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Ionis Pharmaceuticals, Inc. and Amicus Therapeutics, Inc.
R&D Spending Showdown: Ionis Pharmaceuticals, Inc. vs MorphoSys AG
Research and Development Investment: Ionis Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.
Who Prioritizes Innovation? R&D Spending Compared for Ionis Pharmaceuticals, Inc. and Travere Therapeutics, Inc.
Comparing Innovation Spending: Ionis Pharmaceuticals, Inc. and Novavax, Inc.
Research and Development Expenses Breakdown: Ionis Pharmaceuticals, Inc. vs Xencor, Inc.
Viking Therapeutics, Inc. or Evotec SE: Who Invests More in Innovation?